Daily non-political popular news in brief.

First study transplanting angina patients' purified stem cells shows safety and symptom relief

The first U.S. study to transplant a potent form of purified adult stem cells into the heart muscle of patients with severe angina provided evidence that the procedure is safe and produced a reduction in angina pain as well as improved functioning in patients' daily lives, reports Northwestern University. The procedure was an effort to spur regrowth of small blood vessels that constitute the microcirculation of the heart muscle.

Read more »

Keywords: study, transplanting, angina, patients, purified, stem, cells, shows, safety, symptom, relief, patient, cell, show

« Previous | Next »

Similar news on "First study transplanting angina patients' purified stem cells shows safety and symptom relief":

1. UF researchers test stem cell therapy for heart patients
   10-04-2007 · EurekAlert!
   University of Florida doctors treated the first patient in a new study to test whether a person's own stem cells can be used to restore blood flow to the heart by prompting new blood vessels to grow.
   Similar news · Read more »
   
2. Tumor-reactive T cells boosted by hematopoietic stem cell transplantation
   02-01-2007 · EurekAlert!
   Treatment for skin cancer by infusion of tumor-reactive T cells requires patients to be pre-treated with agents that transiently decrease the number of immune cells (nonmyeloablative agents). A study in mice now indicates that pre-treatment with more intense immune cell-depleting strategies (known as myeloablative strategies) and a hematopoietic stem cell transplant enables infused tumor-reactive CD8+ T cells to increase in number more than pre-treatment with nonmyeloablative agents, and this correlates with increased tumor regression.
   Similar news · Read more »
   
3. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
   08-30-2007 · EurekAlert!
   A drug that shuts down a critical cell-signaling pathway in the most common and aggressive type of adult brain cancer successfully kills cancer stem cells thought to fuel tumor growth and help cancers evade drug and radiation therapy, a Johns Hopkins study shows.
   Similar news · Read more »
   
4. Adult stem cell heart attack study updated at American Society for Hematology Meeting
   12-11-2007 · EurekAlert!
   Doctors are using patients' own bone marrow stem cells (progenitor cells) to treat the damage to cardiac muscle after a heart attack in a study at Emory University School of Medicine. The study investigators will update their colleagues on its progress at the American Society of Hematology meeting in Atlanta next week.
   Similar news · Read more »
   
5. Stem cell therapy shows promise in regenerating damaged muscle in heart attack patients
   03-27-2007 · EurekAlert!
   Heart attack patients who received an new intravenous adult stem cell therapy, Provacel, experienced a lower number of adverse events, such as cardiac arrhythmias, and had significant improvements in heart, lung and global function compared to those who received a placebo, according to six-month Phase I study data presented at the American College of Cardiology's Innovation in Intervention: i2 Summit in New Orleans on March 25.
   Similar news · Read more »
   
6. Northwestern Memorial trial may wean kidney transplant patients off antirejection drugs
   01-22-2008 · EurekAlert!
   After transplant surgery, antirejection drugs for the organ recipient are a must. But prolonged use can have serious side effects, including infections, heart disease and even cancer. A team of researchers at Northwestern University's Feinberg School of Medicine is working with Northwestern Memorial Hospital's department of organ transplantation in a new study that seeks to eliminate the need for antirejection drugs by transplanting stem cells from a kidney donor's bone marrow into the organ recipient.
   Similar news · Read more »
   
7. Human Stem Cells Delay Start Of Lou Gehrig's Disease In Rats
   10-15-2006 · ScienceDaily
   Researchers at Johns Hopkins have shown that transplanting human stem cells into spinal cords of rats bred to duplicate Lou Gehrig's disease delays the start of nerve cell damage typical of the disease and slightly prolongs life. The grafted stem cells develop into nerve cells that make substantial connections with existing nerves and do not themselves succumb to Lou Gehrig's, also known as amyotrophic lateral sclerosis (ALS). The study is published in this week's issue of Transplantation.
   Similar news · Read more »
   
8. Other highlights in the December 20 JNCI
   12-19-2006 · EurekAlert!
   Also in the December 20 issue of JNCI -- A report on breast cancer stem cells and radiation; research connecting statin use and advanced prostate cancer; a study of asthma medication and pancreatic cancer cell growth; and a model that predicts the risks of radiation therapy for leukemia patients.
   Similar news · Read more »
   
9. Type of stem cell found to reside in transplanted lungs
   03-08-2007 · EurekAlert!
   A new study involving a type of stem cells from the lungs of transplant patients demonstrates for the first time that these progenitor cells reside in adult organs and are not derived from bone marrow, which leads to the possibility that the cells may be able to help with the rejection of donated organs and with various kinds of lung disease.
   Similar news · Read more »
   
10. Stuck on you: CEACAM6 helps E. coli stick to intestinal lining in Crohn's disease
    05-24-2007 · EurekAlert!
    In Crohn's disease, the lining of the small intestine is abnormally colonized by E. coli organisms that are able to adhere to and invade intestinal epithelial cells. A new JCI study shows that these bacteria adhere to a region of intestinal epithelial cells known as the brush border in patients with Crohn's disease, but not in healthy individuals, and that this adhesion depends on expression of the receptor CEACAM6 on the epithelial cell surface.
    Similar news · Read more »